The relationship between vitamin D deficiency and thoracic aortic dilatation;Die Beziehung zwischen Vitamin D-Mangel und thorakaler Aortendilatation

Vasa - Journal of Vascular Diseases

Volumn 41, Issue 6, 2012, Pages 419-424

  Demir, Mehmet ^a   Uyan, Umut ^a   Melek, Mehmet ^a  

^a BURSA YUKSEK IHTISAS TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Aortic dilatation; Hypertension; Renin angiotensin aldosterone system; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; PARATHYROID HORMONE;

ADULT; AGED; AORTA DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART HEMODYNAMICS; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; THORACIC AORTA; THORACIC AORTIC DILATATION; TRANSTHORACIC ECHOCARDIOGRAPHY; VITAMIN D DEFICIENCY;

ADULT; AGED; AORTA, THORACIC; AORTIC ANEURYSM, THORACIC; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DILATATION, PATHOLOGIC; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PARATHYROID HORMONE; RISK ASSESSMENT; RISK FACTORS; TURKEY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84870179859     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000219     Document Type: Article

References (25)

1. Ahimastos A.A, Aggarwal A, D'Orsa K.M, Formosa M.F, White A.J, Savarirayan R, et al. Eff ect of perindopril on large artery stiff ness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA 2007; 298: 1539-47.
2. Bickerstaff L.K, Pairolero P.C, Hollier L.H, Melton L.J, Van Peenen H.J, Cherry K.J, et al. Th oracic aortic aneurysms: a population-based study. Surgery 1982; 92: 1103-8.
3. Bischoff H.A, Giovannucci E, Willett W.C. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28.
4. Boldo A, Campbell P, Luthra P, White W.B. Should the Concentration of Vitamin D be Measured in All Patients with Hypertension? J Clin Hypertens 2010; 12 (3): 149-152.
5. Booher A.M, Eagle K.A. Diagnosis and management issues in thoracic aortic aneurysm. Am Heart J 2011; 162: 38-46 e1.
6. Cardus A, Parisi E, Gallego C, Aldea M, Fernandez E, Valdivielso J.M. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGFmediated pathway. Kidney Int 2006; 69 (8): 1377-84.
7. Claridge M.W, Hobbs S.D, Quick C.R, Day N.E, Bradbury A.W, Wilmink A.B. ACE inhibitors increase type III collagen synthesis: a potential explanation for reduction in acute vascular events by ACE inhibitors. Eur J Vasc Endovasc Surg 2004; 28: 67-70.
8. Connell J.M, MacKenzie S, Freel E, Fraser R, Davies E. A lifetime of aldosterone excess: long term consequences of alteredregulation of aldosterone production for cardiovascular function. Endocr. Rev 2008; 29: 133-154.
9. Courbebaisse M, Souberbielle J, Thervet E. Potential nonclassical eff ects of vitamin D in transplant recipients. Transplantation 2010; 89: 131-137.
10. Daugherty A, Manning M.W, Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-defi cient mice. J Clin Invest 2000; 105: 1605-12.
11. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. J J Clin Nutr 2004; 80: 1689-96.
12. Forman J.P, Giovannucci E, Holmes M.D, Bischoff-Ferrari H.A, Tworoger S.S, Willett W.C, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49 (5): 1063-9.
13. Habashi J.P, Judge D.P, Holm T.M, Cohn R.D, Loeys B.L, Cooper T.K, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312: 117-21.
14. Hackam D.G, Thiruchelvam D, Redelmeier D.A. Angiotensinconverting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 2006; 368: 659-65.
15. Hagan P.G, Nienaber C.A, Isselbacher E.M, Bruckman D, Karavite D.J, Russman P.L, et al. Th e International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000; 283: 897-903.
16. Judd S.E, Tangpricha V. Vitamin D defi ciency and risk for cardiovascular disease. Am J Med Sci 2009; 338 (1): 40-4.
17. Lilienfeld D.E, Gunderson P.D, Sprafka J.M, Vargas C. Epidemiology of aortic aneurysms: I. Mortality trends in the United States, 1951 to 1981. Arteriosclerosis 1987; 7: 637-43.
18. Lloyd G.M, Newton J.D, Norwood M.G, Franks S.C, Bown M.J, Sayers R.D. Patients with abdominal aortic aneurysm: are we missing the opportunity for cardiovascular risk reduction? J Vasc Surg 2004; 40: 691-7.
19. Lu H, Rateri D.L, Cassis L.A, Daugherty A. Th e role of the renin-angiotensin system in aortic aneurismal diseases. Curr Hypertens Rep 2008; 10: 99-106.
20. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Th ird National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167 (11): 1159-65.
21. Resnick L.M, Muller F.B, Laragh J.H. Calcium regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986; 105: 649-654.
22. Sugden J.A, Davies J.I, Witham M.D, Morris A.D, Struthers A.D. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008; 25: 320-325.
23. Ullah M.I, Uwaifo G.I, Nicholas W.C, Koch C.A. Does vitamin D defi-ciency cause hypertension? Current evidence from clinical studies and potentialmechanisms. Int J Endocrinol 2010: Article ID 579640, 11 pages. doi:10.1155/2010/579640.
24. Wang T.J, Pencina MJ., Booth S.L, Jacques P.F, Ingelsson E, Lanier K, et al. Vitamin D defi ciency and risk of cardiovascular disease. Circulation 2008; 117 (4): 503-11.
25. Yetman A.T, Bornemeier R.A, Mc-Crindle B.W. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol 2005; 95: 1125-7.